MORDOR II Burkina Faso: Longitudinal Trial

NCT03676751 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Child Growth
Diversity of Microbiome
Child Mortality
Resistance Bacterial

Interventions

DRUG: Azithromycin
DRUG: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]